{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:18:34Z","timestamp":1760242714830,"version":"build-2065373602"},"reference-count":21,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2016,4,12]],"date-time":"2016-04-12T00:00:00Z","timestamp":1460419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"DAAD Germany","award":["ID 56266390"],"award-info":[{"award-number":["ID 56266390"]}]},{"name":"Research fund of Chungnam National University"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Neglected tropical diseases (NTDs) affect over one billion people all over the world. These diseases are classified as neglected because they impact populations in areas with poor financial conditions and hence do not attract sufficient research investment. Human African Trypanosomiasis (HAT or sleeping sickness), caused by the parasite Trypanosoma brucei, is one of the NTDs. The current therapeutic interventions for T. brucei infections often have toxic side effects or require hospitalization so that they are not available in the rural environments where HAT occurs. Furthermore, parasite resistance is increasing, so that there is an urgent need to identify novel lead compounds against this infection. Recognizing the wide structural diversity of natural products, we desired to explore and identify novel antitrypanosomal chemotypes from a collection of natural products obtained from plants. In this study, 440 pure compounds from various medicinal plants were tested against T. brucei by in a screening using whole cell in vitro assays. As the result, twenty-two phenolic compounds exhibited potent activity against cultures of T. brucei. Among them, eight compounds\u20144, 7, 11, 14, 15, 18, 20, and 21\u2014showed inhibitory activity against T. brucei, with IC50 values below 5 \u00b5M, ranging from 0.52 to 4.70 \u03bcM. Based on these results, we attempt to establish some general trends with respect to structure-activity relationships, which indicate that further investigation and optimization of these derivatives might enable the preparation of potentially useful compounds for treating HAT.<\/jats:p>","DOI":"10.3390\/molecules21040480","type":"journal-article","created":{"date-parts":[[2016,4,12]],"date-time":"2016-04-12T10:57:33Z","timestamp":1460458653000},"page":"480","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Phenolic Constituents of Medicinal Plants with Activity against Trypanosoma brucei"],"prefix":"10.3390","volume":"21","author":[{"given":"Ya","family":"Sun","sequence":"first","affiliation":[{"name":"College of Pharmacy, Chungnam National University, Daejeon 305-764, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joo","family":"No","sequence":"additional","affiliation":[{"name":"Leishmania Research Laboratory, Institut Pasteur Korea, 696 Sampyeong-dong, Bundang-gu, Seongnam-si, Gyeonggi 463-400, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0932-4418","authenticated-orcid":false,"given":"Ga","family":"Lee","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Chungnam National University, Daejeon 305-764, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[{"name":"School of Biotechnology, Yeungnam University, Gyeongsan, Gyeongbuk 712-749, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seo","family":"Yang","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Chungnam National University, Daejeon 305-764, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyongseon","family":"Yang","sequence":"additional","affiliation":[{"name":"Leishmania Research Laboratory, Institut Pasteur Korea, 696 Sampyeong-dong, Bundang-gu, Seongnam-si, Gyeonggi 463-400, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2634-9705","authenticated-orcid":false,"given":"Thomas","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Biology and Phytochemistry (IPBP), University of M\u00fcnster, PharmaCampus, Corrensstrasse 48, D-48149 M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong","family":"Kang","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Chungnam National University, Daejeon 305-764, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young","family":"Kim","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Chungnam National University, Daejeon 305-764, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2016,4,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/00001432-200012000-00012","article-title":"Problems for the chemotherapy of human African trypanosomiasis","volume":"13","author":"Barrett","year":"2000","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_2","first-page":"1","article-title":"Developments in the treatment of leishmaniasis and trypanosomiasis","volume":"7","author":"Olliario","year":"2002","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1055\/s-0030-1250411","article-title":"Sleeping sickness pathogen (Trypanosoma brucei) and natural products: Therapeutic targets and screening systems","volume":"77","author":"Hannaert","year":"2011","journal-title":"Planta Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0308-521X(98)00086-9","article-title":"Measuring the costs of African animal trypanosomosis, the potential benefits of control and returns to research","volume":"59","author":"Kristjanson","year":"1999","journal-title":"Agric. Syst."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1471-4922(00)01839-0","article-title":"Sleeping sickness: A tale of two diseases","volume":"17","author":"Welburn","year":"2001","journal-title":"Trends Parasitol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Simarro, P.P., Cecchi, G., Franco, J.R., Paone, M., Diarra, A., Ruiz-Postigo, J.A., F\u00e8vre, E.M., Mattioli, R.C., and Jannin, J.G. (2012). Estimating and mapping the population at risk of sleeping sickness. PLoS Negl. Trop. Dis., 6.","DOI":"10.1371\/journal.pntd.0001859"},{"key":"ref_7","first-page":"1","article-title":"Control and Surveillance of African Trypanosomiasis Report of a WHO Expert Committee","volume":"984","author":"WHO","year":"2013","journal-title":"WHO Tech. Rep. Ser."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ana.21429","article-title":"The continuing problem of human African trypanosomiasis (sleeping sickness)","volume":"64","author":"Kennedy","year":"2008","journal-title":"Ann. Neurol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/QCO.0b013e32833f9fd0","article-title":"Potential new drugs for human African trypanosomiasis: Some progress at last","volume":"23","author":"Barrett","year":"2010","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.4155\/fmc.13.162","article-title":"Drug discovery and human African trypanosomiasis: A disease less neglected","volume":"5","author":"Ferrins","year":"2013","journal-title":"Future Med. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1007\/s00436-002-0752-y","article-title":"Current chemotherapy of human African trypanosomiasis","volume":"90","author":"Docampo","year":"2003","journal-title":"Parasitol. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-308X(08)60410-8","article-title":"The treatment of human African trypanosomiasis","volume":"33","author":"Pepin","year":"1994","journal-title":"Adv. Parasitol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.2174\/092986712800229023","article-title":"The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases\u2014Part I","volume":"19","author":"Schmidt","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.2174\/092986712800229087","article-title":"The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases\u2014Part II","volume":"19","author":"Schmidt","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1128\/AAC.50.4.1352-1364.2006","article-title":"Antitrypanosomal and antileishmanial activities of flavonoids and their analogues: In Vitro, in Vivo, structure-activity relationship, and quantitative structure-activity relationship studies","volume":"50","author":"Tasdemir","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ejmech.2009.11.035","article-title":"Curcuminoid analogs with potent activity against Trypanosoma and Leishmania species","volume":"45","author":"Changtam","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"ref_17","unstructured":"MOE\u2014Molecular Operating Environment v. 2014.0901. For details on molecular descriptors see: http:\/\/www.chemcomp.com\/journal\/descr.htm."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/1521-3838(200208)21:3<276::AID-QSAR276>3.0.CO;2-S","article-title":"Quantitative Structure-Cytotoxicity Relationships of Sesquiterpene Lactones derived from Partial Charge (Q)-based Fractional Accessible Surface Area Descriptors (Q_frASAs)","volume":"21","author":"Schmidt","year":"2002","journal-title":"Quant. Struct. Act. Relat."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0166-1280(99)00360-7","article-title":"Molecular fields in quantitative structure-permeation relationships: The VolSurf approach","volume":"503","author":"Cruciani","year":"2000","journal-title":"J. Mol. Struct."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"7869","DOI":"10.3390\/molecules19067869","article-title":"Secondary metabolites from vietnamese marine invertebrates with activity against Trypanosoma brucei and T. cruzi","volume":"19","author":"Thao","year":"2014","journal-title":"Molecules"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"12459","DOI":"10.3390\/molecules200712459","article-title":"Anti-protozoal activities of cembrane-type diterpenes from Vietnamese soft Corals","volume":"20","author":"Thao","year":"2015","journal-title":"Molecules"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/21\/4\/480\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:22:08Z","timestamp":1760210528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/21\/4\/480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,12]]},"references-count":21,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4]]}},"alternative-id":["molecules21040480"],"URL":"https:\/\/doi.org\/10.3390\/molecules21040480","relation":{},"ISSN":["1420-3049"],"issn-type":[{"type":"electronic","value":"1420-3049"}],"subject":[],"published":{"date-parts":[[2016,4,12]]}}}